Biovie Inc (BIVI)

$1.83 +0.21 (12.96%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	11.46M
Revenue (ttm)	0.00
Net Income (ttm)	-17.54M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	293,597
Avg Vol	183,872
Day's Range	N/A - N/A
Shares Out	7.54M
Stochastic %K	92%
Beta	0.57
Analysts	Strong Buy
Price Target	$12.00

Company Profile

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as fo...

Industry: Biotechnology

Sector: Healthcare

Phone: 775 888 3162

Website: bioviepharma.com

Address:

680 W. Nye Lane, Suite 204, Carson City, United States

TwinTurboBul161 Aug. 4 at 7:01 PM

$BIVI $ALOY Gem7

0 · Reply

TwinTurboBul161 Aug. 4 at 4:23 PM

$BIVI $ENVB Sash

0 · Reply

TJ12000 Aug. 4 at 12:46 PM

$BIVI gypsi scam

0 · Reply

Rod75b15 Aug. 4 at 10:53 AM

$BIVI

0 · Reply

TwinTurboBul161 Aug. 3 at 11:39 PM

$ORCL & $BIVI watching

0 · Reply

Mkt_predictor Aug. 3 at 5:11 PM

$BIVI This company is doing things in reverse. usually you release good news, let the stock run up, and then do a raise. this is just comical what theyre doing and shows how amateur mgmt is.

0 · Reply